Physician profile
Christopher A Haas
NPI 1073502720
$470.46
in general payments reported to CMS, 2019-2025
13 companies · $37.00 in 2025
The $37.00 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.74 · 2021: $61.03 · 2022: $113 · 2024: $220 · 2025: $37.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $118.39 | 2024 | Sir-Spheres Microspheres |
| Boston Scientific Corporation | $101.62 | 2024 | Spaceoar System |
| Dexcom, INC. | $35.63 | 2022 | |
| Abbvie INC. | $33.75 | 2022 | |
| Stryker Corporation | $29.84 | 2021 | |
| Antares Pharma, INC. | $28.12 | 2022 | |
| Shionogi INC | $24.19 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.67 | 2025 | Lifevest |
| Teleflex LLC | $19.98 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $15.55 | 2019 | |
| Ambu INC. | $15.33 | 2025 | |
| Convatec INC. | $15.18 | 2022 | |
| Innocoll Pharmaceuticals Limited | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.